Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Plasma cell 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Congenital Abnormalities 2Burkitt Lymphoma 2Blast Crisis 2Anemia, Refractory, with Excess of Blasts 2Recurrence 1

Interventions

Peripheral Blood Stem Cell Transplantation 19Tacrolimus 14Mycophenolic Acid 14Cyclophosphamide 14fludarabine phosphate 12Cyclosporine 12Whole-Body Irradiation 10Therapeutics 8Psychiatric Rehabilitation 8Methotrexate 8Flow Cytometry 8Radiotherapy 7Methylprednisolone 7Filgrastim 7Busulfan 7Antilymphocyte Serum 7Polymerase Chain Reaction 6Ondansetron 4Etoposide 4Cord Blood Stem Cell Transplantation 4merphos 3Sirolimus 3Melphalan 3Interferon-alpha 3Early Intervention, Educational 3Dexamethasone 3Calcium Dobesilate 3Aprepitant 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × Carmustine × Myeloid × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡